From: Malaria hospitalisation in East Africa: age, phenotype and transmission intensity
Indicators | PfPR2–10 <  5% | PfPR2–10 5-9% | PfPR2–10 10–29% | PfPR2–10 ≥ 30% | Overall |
---|---|---|---|---|---|
No. of sites (date range) | 12 (2006–2021) | 5 (2012–2021) | 20 (2006–2021) | 12 (2006–2021) | 49 (2006–2021) |
Site-time in months | 447 | 158 | 736 | 371 | 1712 |
All-cause malaria | 1431 | 1540 | 31885 | 17828 | 52684 |
Mean age months (95% CI) | 49.5 (45.1, 55.4) | 47.2 (43.5, 51.6) | 41.7 (39.2, 44.5) | 34.1 (30.4, 38.3) | 42.1 (39.1, 45.2) |
Age-specific probabilities (%) | Â | Â | Â | Â | Â |
 2–11 age in months (95% CI) | 10.3 (8.8, 11.8) | 11.1 (9.7, 12.4) | 13.2 (12.1, 14.4) | 17.4 (14.9, 20.2) | 13.1 (11.8, 14.5) |
 2–23 age in months (95% CI) | 27.5 (24.0, 30.8) | 29.2 (26.2, 32.1) | 33.8 (31.3, 36.2) | 42.0 (37.2, 47.1) | 33.4 (30.8, 36.3) |
 Under 5 years (95% CI) | 69.4 (64.0, 73.8) | 71.7 (67.4, 75.4) | 77.3 (74.4, 79.9) | 85.2 (80.9, 88.9) | 76.9 (73.7, 79.9) |
Mortality (95% CI);¶ n/N (no. of sites) | 3.2% (2.3, 4.3) 45/1406 (12) | 2.0% (1.4, 2.9) 31/1518 (5) | 1.8% (1.7, 2.0) 532/28774 (20) | 1.0% (0.9, 1.2) 166/16672 (12) | 1.5% (1.4, 1.7) 744/48370 (49) |
Severe malaria anaemia* (%) n/N (no. of sites) | 8.6% 115/1341Â (12) | 5.4% 66/1229Â (5) | 27.0% 3798/14088Â (20) | 14.8% 1281/8663Â (12) | 20.8% 5260/25321Â (49) |
Mean age months (95% CI) | 44.6 (39.5, 50.6) | 42.5 (38.1, 47.7) | 37.7 (34.2, 41.5) | 31.1 (27.4, 35.1) | 39.0 (35.3, 42.7) |
Age-specific probabilities (%) | Â | Â | Â | Â | Â |
 2–11 age in months (95% CI) | 11.5 (9.4, 13.7) | 12.3 (10.4, 14.5) | 14.6 (12.7, 16.8) | 19.1 (16.1, 22.6) | 14.0 (12.2, 16.2) |
 2–23 age in months (95% CI) | 30.7 (26.2, 35.4) | 32.5 (28.2, 36.9) | 37.4 (33.3, 41.6) | 45.9 (40.4, 51.7) | 36.0 (32.3, 40.2) |
 Under 5 years (95% CI) | 74.5 (68.4, 79.8) | 76.7 (71.3, 81.3) | 81.8 (77.7, 85.5) | 88.6 (84.5, 92.0) | 80.3 (76.4, 84.2) |
Mortality (95% CI);¶ n/N (no. of sites) | 8.3% (3.9, 15.2) 9/108 (12) | 9.5% (3.6, 19.6) 6/63 (5) | 5.3% (4.5, 6.1) 170/3209 (20) | 4.2% (3.1, 5.5) 49/1169 (12) | 5.1% (4.5, 5.8) 234/4549 (49) |
Respiratory distress (%) n/N (no. of sites) | 6.0% 85/1426Â (12) | 10.6% 162/1531Â (5) | 9.5% 2740/28808Â (18) | 4.8% 615/12884Â (8) | 8.1% 3602/44649Â (43) |
Mean age months (95% CI) | 40.1 (35.2, 46.0) | 38.1 (33.9, 43.4) | 33.8 (30.3, 38.2) | 27.9 (24.2, 32.4) | 33.7 (30.3, 37.1) |
Age-specific probabilities (%) | Â | Â | Â | Â | Â |
 2–11 age in months (95% CI) | 13.4 (10.9, 16.1) | 14.4 (11.9, 17.0) | 17.0 (14.3, 19.8) | 22.1 (18.1, 26.4) | 17.2 (15.0, 19.8) |
 2–23 age in months (95% CI) | 34.8 (29.5, 40.3) | 36.8 (31.6, 42.0) | 42.0 (36.8, 47.0) | 50.9 (44.0, 57.7) | 42.2 (38.0, 47.0) |
 Under 5 years (95% CI) | 79.2 (73.0, 84.4) | 81.2 (75.7, 85.8) | 85.8 (81.2, 89.3) | 91.6 (87.2, 94.6) | 85.9 (82.3, 89.3) |
Mortality (95% CI);¶ n/N (no. of sites) | 12.9% (6.6, 22.0) 11/85 (11) | 6.3% (3.1, 11.3) 10/158 (3) | 6.1% (5.1, 7.1) 147/2427 (17) | 5.8% (4.0, 8.1) 32/553 (8) | 6.2% (5.4, 7.1) 200/3223 (39) |
Cerebral malaria (%) n/N (no. of sites) | 4.2% 60/1423Â (12) | 5.3% 81/1530Â (5) | 3.1% 945/30494Â (20) | 0.6% 105/17052Â (12) | 2.4% 1191/50499Â (49) |
Mean age months (95% CI) | 56.2 (49.0, 64.9) | 53.5 (47.1, 61.1) | 47.4 (42.1, 53.5) | 39.1 (33.9, 45.1) | 48.7 (43.3, 54.1) |
Age-specific probabilities (%) | Â | Â | Â | Â | Â |
 2–11 age in months (95% CI) | 8.1 (6.4, 10.0) | 8.7 (7.0, 10.6) | 10.5 (8.7, 12.5) | 13.9 (11.2, 17.1) | 10.1 (8.6, 12.1) |
 2–23 age in months (95% CI) | 22.8 (18.7, 27.3) | 24.4 (20.3, 28.6) | 28.4 (24.3, 32.9) | 35.8 (30.1, 42.0) | 27.6 (24.0, 31.9) |
 Under 5 years (95% CI) | 63.2 (55.9, 70.0) | 65.6 (58.9, 71.9) | 71.5 (65.6, 77.0) | 80.3 (73.9, 85.8) | 70.3 (65.0, 75.7) |
Mortality (95% CI);¶ n/N (no. of sites) | 13.3% (5.9, 24.6) 8/60 (9) | 13.8% (7.1, 23.3) 11/80 (4) | 13.7% (11.4, 16.2) 115/840 (17) | 14.4% (7.9, 23.4) 13/90 (11) | 13.7% (11.7, 15.9) 147/1070 (41) |